CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: Prevention of Cefoperazone-induced Coagulopathy [Phase 4]
Summary
Phase 4 clinical trial update investigating prevention of cefoperazone-induced coagulopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helwan University | Conditions: Antibiotic Side Effect | Phase 4 | Status: COMPLETED